Skip to main content
SpringerLink
Log in

Pankreaskarzinom

Adjuvante Chemotherapie mit modifiziertem FOLFIRINOX-Regime

  • journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  • Conroy T, Hammel P, Hebbar M et al. For the canadian cancer trials group and the unicancer-GI—PRODIGE Group* FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 2018;379:2395–406

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik, St. Joseph-Hospital Bremen, Schwachhauser Heerstraße 54, 28209, Bremen, Deutschland

    Christian Pox

Authors
  1. Christian Pox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Pox.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pox, C. Adjuvante Chemotherapie mit modifiziertem FOLFIRINOX-Regime. Gastro-News 6, 19–20 (2019). https://doi.org/10.1007/s15036-019-0654-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-019-0654-9

Search

Navigation